469 related articles for article (PubMed ID: 24864075)
1. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
2. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
3. Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.
Kobayashi T; Ito S; Kobayashi D; Shimada A; Narita I; Murasawa A; Nakazono K; Yoshie H
PLoS One; 2016; 11(4):e0154182. PubMed ID: 27111223
[TBL] [Abstract][Full Text] [Related]
4. Bacterial citrullinated epitopes generated by
Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
[TBL] [Abstract][Full Text] [Related]
5. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
[TBL] [Abstract][Full Text] [Related]
7. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
Vitkov L; Hannig M; Minnich B; Herrmann M
Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
[TBL] [Abstract][Full Text] [Related]
8. Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.
Fisher BA; Cartwright AJ; Quirke AM; de Pablo P; Romaguera D; Panico S; Mattiello A; Gavrila D; Navarro C; Sacerdote C; Vineis P; Tumino R; Lappin DF; Apatzidou D; Culshaw S; Potempa J; Michaud DS; Riboli E; Venables PJ
BMC Musculoskelet Disord; 2015 Nov; 16():331. PubMed ID: 26537917
[TBL] [Abstract][Full Text] [Related]
9. PPAD is not targeted as a citrullinated protein in rheumatoid arthritis, but remains a candidate for inducing autoimmunity.
Konig MF; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Jan; 74(1):e8. PubMed ID: 25381231
[No Abstract] [Full Text] [Related]
10. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.
Castellar-Mendoza C; Castillo DM; Chila-Moreno L; Bautista-Molano W; Romero-Sánchez C
Clin Oral Investig; 2023 Jul; 27(7):3509-3519. PubMed ID: 37133700
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
[TBL] [Abstract][Full Text] [Related]
12. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).
Maresz KJ; Hellvard A; Sroka A; Adamowicz K; Bielecka E; Koziel J; Gawron K; Mizgalska D; Marcinska KA; Benedyk M; Pyrc K; Quirke AM; Jonsson R; Alzabin S; Venables PJ; Nguyen KA; Mydel P; Potempa J
PLoS Pathog; 2013 Sep; 9(9):e1003627. PubMed ID: 24068934
[TBL] [Abstract][Full Text] [Related]
13. The link between periodontal disease and rheumatoid arthritis: an updated review.
Koziel J; Mydel P; Potempa J
Curr Rheumatol Rep; 2014 Mar; 16(3):408. PubMed ID: 24458478
[TBL] [Abstract][Full Text] [Related]
14. Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.
Laugisch O; Wong A; Sroka A; Kantyka T; Koziel J; Neuhaus K; Sculean A; Venables PJ; Potempa J; Möller B; Eick S
Clin Oral Investig; 2016 May; 20(4):675-83. PubMed ID: 26264638
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
[TBL] [Abstract][Full Text] [Related]
16. PPAD remains a credible candidate for inducing autoimmunity in rheumatoid arthritis: comment on the article by Konig et al.
Quirke AM; Lundberg K; Potempa J; Mikuls TR; Venables PJ
Ann Rheum Dis; 2015 Jan; 74(1):e7. PubMed ID: 25311822
[No Abstract] [Full Text] [Related]
17. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.
Li S; Yu Y; Yue Y; Liao H; Xie W; Thai J; Mikuls TR; Thiele GM; Duryee MJ; Sayles H; Payne JB; Klassen LW; O'Dell JR; Zhang Z; Su K
Arthritis Rheumatol; 2016 Mar; 68(3):614-26. PubMed ID: 26474325
[TBL] [Abstract][Full Text] [Related]
19. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.
Bielecka E; Scavenius C; Kantyka T; Jusko M; Mizgalska D; Szmigielski B; Potempa B; Enghild JJ; Prossnitz ER; Blom AM; Potempa J
J Biol Chem; 2014 Nov; 289(47):32481-7. PubMed ID: 25324545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
